Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity
Advances in Respiratory Medicine · 20.10.2021 · 89 (5) · 511-519
DOI: 10.5603/arm.a2021.0085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 20.10.2021. Verfasst von Ioannis Tsamis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, Third Department of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Messogion, Athens, Greece. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pulmonary blastoma is a rare malignancy, accounting for less than 0.5% of primary lung tumors. It belongs to the group of pulmonary sarcomatoid carcinomas, and it is typically characterized by a biphasic pattern of an epithelial and a mesenchymal component. Only a few hundred cases have been reported worldwide. The aim of this study is to review and critically assess the literature regarding pulmonary blastoma. Material and methods: A narrative literature review of PubMed database from the inception of the database up to January 2021, limited to the English language, was conducted, using combinations of the following keywords: “pulmonary blastoma”, “biphasic pulmonary blastoma”, “sarcomatoid carcinoma”.
Results
Pulmonary blastoma is composed of an epithelial and a mesenchymal malignant component. Regarding pathogenesis, the origin of the biphasic cell population remains elusive. Characteristic immunohistochemical stains are supportive of diagnosis.Clinically, the symptomatology is non-specific, while 40% of the cases are asymptomatic. It is diagnosed at a younger agecompared to other types of lung cancer, and it is often non-metastatic at diagnosis allowing for surgical treatment. Data on management and survival are scarce and mainly come from isolated cases. Advances on targeted therapy may provide novel treatment options. Given the rarity of the cases, multicenter collaboration is needed in order to establish therapeutic Guideliness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Unit, Third Department of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Messogion, Athens, Greece.
- 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
- Oncology Unit, Third Department of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Messogion, Athens, Greece. georgia.gomatou@gmail.com.
- Pathology Department, Sotiria General Hospital, Messogion, Athens, Greece.
ORCID-Profile: Georgia Gomatou
Zitieren
APA
Tsamis, I., Chachali, S. P., Gomatou, G., Trontzas, I., Mitsogianni, M., Syrigos, N., Vamvakaris, I., & Kotteas, E. (2021). Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity. Advances in Respiratory Medicine, 89(5), 511-519. https://doi.org/10.5603/arm.a2021.0085
Vancouver
Tsamis I, Chachali SP, Gomatou G, Trontzas I, Mitsogianni M, Syrigos N, et al. Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity. Advances in Respiratory Medicine. 2021;89(5):511-519. doi:10.5603/arm.a2021.0085
BibTeX
@article{Tsamis2021,
author = {Tsamis, Ioannis and Chachali, Stavroula-Porfyria and Gomatou, Georgia and Trontzas, Ioannis and Mitsogianni, Maria and Syrigos, Nikolaos and Vamvakaris, Ioannis and Kotteas, Elias},
title = {Pulmonary Blastoma: A Comprehensive Overview of A Rare Entity},
journal = {Advances in Respiratory Medicine},
year = {2021},
volume = {89},
number = {5},
pages = {511--519},
doi = {10.5603/arm.a2021.0085}
}
EUVIMED